GenoME Diagnostics and SonoTarg Ltd win €20,000 at Seedcorn Competition

Belfast based GenoME Diagnostics and SonoTarg Ltd have been have been crowned ‘Best New Start’ company and ‘Best Early Stage’ company respectively at the Belfast regional final of the 2020 InterTradeIreland Seedcorn Investor Readiness Competition.
Shannon Beattie, COO at GenoME DiagnosticsShannon Beattie, COO at GenoME Diagnostics
Shannon Beattie, COO at GenoME Diagnostics

Both companies fought off tough competition having delivered an investment pitch via video conference in front of an expert judging panel.

Seedcorn is the island’s biggest business competition for innovative new start and early stage businesses in any sector. The winners from each of the four regions will go onto compete in the all-island final on Wednesday, December 2 where the overall ‘Best New Start’ and ‘Best Early Stage’ companies will be announced winning €50,000 each, and ultimately the ‘Overall Winner’ will pocket €100,000 to contribute to their business growth.

Hide Ad
Hide Ad

GenoME Diagnostics was established in 2020 as a spin out of the Patrick G Johnston Centre for Cancer Research at Queen’s University, Belfast. Founded based on research conducted by Dr Paul Mullan, Dr James Beirne and Dr Laura Feeney, the company is developing a blood test for the earlier diagnosis of ovarian cancer.

Sono Targ, Chief Scientific Officer, Professor John CallanSono Targ, Chief Scientific Officer, Professor John Callan
Sono Targ, Chief Scientific Officer, Professor John Callan

Shannon Beattie, COO at GenoME Diagnostics said; “Winning ‘Best New Start company at the Northern Ireland final is a great success for us. We are aiming to supply our innovative ovarian cancer diagnostic globally and this prize money will provide us with a fantastic opportunity to increase our business visibility and networking opportunities at various international conferences and tradeshows.”

SonoTarg Ltd , an Ulster University spin out was established in 2018 has developed a new targeted ultrasound therapy for treatment of solid cancer tumours which claims to be more effective and less toxic than conventional chemotherapy.

Chief Scientific Officer, Professor John Callan explained; “We are delighted to win ‘Best Early stage’ company at the Northern Ireland regional final and progress to the next stage of the competition, were we will compete for the overall Seedcorn title. Having demonstrated the effectiveness of SonoTarg in a range of pre-clinical tumour models, our next step is to test the technology in a first-in-human clinical trial. The advice obtained throughout the Seedcorn competition will be very beneficial when engaging with investors to raise the funding needed to complete this next phase of SonoTarg’s development.”

Hide Ad
Hide Ad

Since the competition’s inception in 2003, more than 3,100 companies have been through the programme and finalists have raised in excess of €256m in equity funding, emphasising Seedcorn’s position as the premier competition for high growth start-up companies on the island.

Connor Sweeney, Seedcorn Programme Manager at InterTradeIreland said: “It’s a great achievement to win the regional final, the standard of entries from Northern Ireland this year has been particularly high. Congratulations to GenoME Diagnostics and SonoTarg Ltd, both companies demonstrated vision, innovation and passion, all of which the judges look for when assessing the potential and longevity of a business. I wish them luck as they go on to compete against other jurisdictions in the competition’s overall final next month.”

Further details are also available on the Seedcorn website at www.intertradeireland.com/seedcorn and follow on twitter @Inter_Trade

A message from the Editor:

Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.

Hide Ad
Hide Ad

In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.

Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.

With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.

You can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to newsletter.co.uk

Hide Ad
Hide Ad

With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit https://www.newsletter.co.uk/subscriptions now to sign up.

Thank you